Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen. 2011

Singanallur Balasubramanian Nagendrakumar, and Villuppanoor Alwar Srinivasan, and Muthukrishnan Madhanmohan, and Shanmugam Yuvaraj, and Satya Parida, and Antonello Di Nardo, and Jacquelyn Horsington, and David James Paton
Foot-and-Mouth Disease Virus Laboratory, Research and Development Centre, Indian Immunologicals Limited, Rakshapuram, Gachibowli Post, Hyderabad 500032, India.

Serology is used to predict vaccine induced protection against challenge with a heterologous strain of the same serotype of foot-and-mouth disease virus (FMDV). To evaluate the accuracy of such predictions, we compared the protection afforded to cattle vaccinated with the O(1) Manisa strain of FMDV against challenge with either a homologous (O(1) Manisa) or a heterologous strain (O(1) Campos). Serology by virus neutralization test (VNT) using O(1) Manisa antiserum predicted an acceptable protection against such a challenge. Two experiments were carried out to compare the results for consistency. A total of 78 naïve cattle were vaccinated with different antigen payloads (60-0.94 μg) of O(1) Manisa. They were challenged by intradermolingual inoculation with live FMDV, either O(1) Manisa or O(1) Campos. Unvaccinated naïve control cattle (n=20) were also challenged with either the O(1) Manisa or O(1) Campos viruses and all developed generalized FMD. The protection results for the vaccinated cattle revealed that higher payloads of O(1) Manisa vaccine were needed to protect against heterologous challenge compared to that for homologous challenge. The 50% protective dose (PD(50)) values for the vaccine in experiments 1 and 2 were found to be 28.78 and 9.44 for the homologous challenge and 3.98 and 5.01 for heterologous challenge. Furthermore, protection against O(1) Campos required a higher level of vaccine-induced antibody against this virus compared to the level of O(1) Manisa neutralizing antibody associated with protection against homologous challenge. The 50% protective level of in vitro neutralizing antibody was found to be log(10)1.827 for O(1) Campos and log(10)0.954 for O(1) Manisa based on O(1) Manisa based virus neutralization test.

UI MeSH Term Description Entries
D009500 Neutralization Tests The measurement of infection-blocking titer of ANTISERA by testing a series of dilutions for a given virus-antiserum interaction end-point, which is generally the dilution at which tissue cultures inoculated with the serum-virus mixtures demonstrate cytopathology (CPE) or the dilution at which 50% of test animals injected with serum-virus mixtures show infectivity (ID50) or die (LD50). Neutralization Test,Test, Neutralization,Tests, Neutralization
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D002418 Cattle Diseases Diseases of domestic cattle of the genus Bos. It includes diseases of cows, yaks, and zebus. Bovine Diseases,Bovine Disease,Cattle Disease,Disease, Bovine,Disease, Cattle,Diseases, Bovine,Diseases, Cattle
D005536 Foot-and-Mouth Disease A highly infectious disease caused by FOOT AND MOUTH DISEASE VIRUS that affects mammals of the ARTIODACTYLA order (CATTLE; SHEEP; GOATS; and PIGS) and is characterized by high fever followed by the appearance of blisters inside the mouth and on the feet. Foot and Mouth Disease,Disease, Foot-and-Mouth,Diseases, Foot-and-Mouth,Foot-and-Mouth Diseases
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000956 Antigens, Viral Substances elaborated by viruses that have antigenic activity. Viral Antigen,Viral Antigens,Antigen, Viral
D014765 Viral Vaccines Suspensions of attenuated or killed viruses administered for the prevention or treatment of infectious viral disease. Viral Vaccine,Vaccine, Viral,Vaccines, Viral
D056738 Cross Protection Protection conferred on a host by inoculation with one strain or component of a microorganism that prevents infection when later challenged with a similar strain. Most commonly the microorganism is a virus. Protection, Cross
D057134 Antibodies, Neutralizing Antibodies that reduce or abolish some biological activity of a soluble antigen or infectious agent, usually a virus. Neutralizing Antibodies,Antibody, Neutralizing,Neutralizing Antibody
D029544 Foot-and-Mouth Disease Virus The type species of APHTHOVIRUS, causing FOOT-AND-MOUTH DISEASE in cloven-hoofed animals. Several different serotypes exist. Foot and Mouth Disease Virus,Foot-and-Mouth Disease Viruses

Related Publications

Singanallur Balasubramanian Nagendrakumar, and Villuppanoor Alwar Srinivasan, and Muthukrishnan Madhanmohan, and Shanmugam Yuvaraj, and Satya Parida, and Antonello Di Nardo, and Jacquelyn Horsington, and David James Paton
February 2017, Virology,
Singanallur Balasubramanian Nagendrakumar, and Villuppanoor Alwar Srinivasan, and Muthukrishnan Madhanmohan, and Shanmugam Yuvaraj, and Satya Parida, and Antonello Di Nardo, and Jacquelyn Horsington, and David James Paton
February 1979, The Journal of hygiene,
Singanallur Balasubramanian Nagendrakumar, and Villuppanoor Alwar Srinivasan, and Muthukrishnan Madhanmohan, and Shanmugam Yuvaraj, and Satya Parida, and Antonello Di Nardo, and Jacquelyn Horsington, and David James Paton
October 2011, Vaccine,
Singanallur Balasubramanian Nagendrakumar, and Villuppanoor Alwar Srinivasan, and Muthukrishnan Madhanmohan, and Shanmugam Yuvaraj, and Satya Parida, and Antonello Di Nardo, and Jacquelyn Horsington, and David James Paton
January 2005, Polish journal of veterinary sciences,
Singanallur Balasubramanian Nagendrakumar, and Villuppanoor Alwar Srinivasan, and Muthukrishnan Madhanmohan, and Shanmugam Yuvaraj, and Satya Parida, and Antonello Di Nardo, and Jacquelyn Horsington, and David James Paton
January 1988, Revista Argentina de microbiologia,
Singanallur Balasubramanian Nagendrakumar, and Villuppanoor Alwar Srinivasan, and Muthukrishnan Madhanmohan, and Shanmugam Yuvaraj, and Satya Parida, and Antonello Di Nardo, and Jacquelyn Horsington, and David James Paton
January 1972, Archiv fur die gesamte Virusforschung,
Singanallur Balasubramanian Nagendrakumar, and Villuppanoor Alwar Srinivasan, and Muthukrishnan Madhanmohan, and Shanmugam Yuvaraj, and Satya Parida, and Antonello Di Nardo, and Jacquelyn Horsington, and David James Paton
March 2021, Vaccine,
Singanallur Balasubramanian Nagendrakumar, and Villuppanoor Alwar Srinivasan, and Muthukrishnan Madhanmohan, and Shanmugam Yuvaraj, and Satya Parida, and Antonello Di Nardo, and Jacquelyn Horsington, and David James Paton
July 2019, Veterinary microbiology,
Singanallur Balasubramanian Nagendrakumar, and Villuppanoor Alwar Srinivasan, and Muthukrishnan Madhanmohan, and Shanmugam Yuvaraj, and Satya Parida, and Antonello Di Nardo, and Jacquelyn Horsington, and David James Paton
April 2023, Vaccines,
Singanallur Balasubramanian Nagendrakumar, and Villuppanoor Alwar Srinivasan, and Muthukrishnan Madhanmohan, and Shanmugam Yuvaraj, and Satya Parida, and Antonello Di Nardo, and Jacquelyn Horsington, and David James Paton
February 2023, Vaccines,
Copied contents to your clipboard!